Vimarsana
Biggest News Aggregation in the World

Page 4 - Cerence Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cerence Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cerence Inc Today - Breaking & Trending Today

North American Morning Briefing : Rate Doubts Keep -2- - 2024-02-06 - Vimarsana News

North American Morning Briefing : Rate Doubts Keep -2- - 2024-02-06

WASHINGTON-Four years ago, when President Biden clinched the Democratic nomination, he aggressively courted progressives, forming an alliance that helped propel him to the White House and has... -February 06, 2024 at 06:15 am EST - MarketScreener

Cerence: Fiscal Q1 Earnings Snapshot -February 06, 2024 at 07:14 am EST - Vimarsana News

Cerence: Fiscal Q1 Earnings Snapshot -February 06, 2024 at 07:14 am EST

BURLINGTON, Mass. — BURLINGTON, Mass. — Cerence Inc. on Tuesday reported profit of $23.9 million in its fiscal first quarter. The Burlington, Massachusetts-based company said it had...

Volkswagen Launches AI Lab, Partners with Global Tech Firms to Make Digital Prototypes - Vimarsana News

Volkswagen Launches AI Lab, Partners with Global Tech Firms to Make Digital Prototypes

Volkswagen establishes an independent AI lab for cutting-edge digital prototypes, focusing on AI-optimized charging, predictive maintenance, and voice recognition, fostering global tech collaborations for innovation.

CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO - CytoDyn (OTC:CYDY) - Vimarsana News

CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO - CytoDyn (OTC:CYDY)

VANCOUVER, Washington, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for

CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO - Vimarsana News

CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO

VANCOUVER, Washington, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ('CytoDyn' or the 'Company'), a biotechnology company develo...